Presentation
13 March 2024 Optical biopsy of brain tumors using fluorescence lifetime imaging (FLIm)
Author Affiliations +
Abstract
Stereotactic needle biopsy is a time-consuming and invasive procedure that often cannot accurately distinguish recurrent tumors from treatment effect in gliomas. We report an intraoperative multispectral fluorescence lifetime imaging (FLIm) system coupled with a custom-made fiber optic probe integrated with the stealth biopsy needle as an optical biopsy tool. FLIm parameters collected from 3 suspected recurrent glioma patients changed over the biopsy trajectory as the needle passed different brain areas. An SVM classifier validated using a leave-one-patient-out validation scheme could identify the lesions from the normal surrounding tissue with sensitivity=0.99, specificity=0.91, and accuracy=0.95.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Silvia N. Noble Anbunesan, Alba Alfonso Garcia, Julien Bec, Mohamed Hassan, Lisanne Kraft, Matthew Bobinski, Han Sung Lee, Lee-Way Jin, Orin Bloch, and Laura Marcu "Optical biopsy of brain tumors using fluorescence lifetime imaging (FLIm)", Proc. SPIE PC12831, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XXII, PC1283101 (13 March 2024); https://doi.org/10.1117/12.3001898
Advertisement
Advertisement
KEYWORDS
Biopsy

Brain

Fluorescence lifetime imaging

Neuroimaging

Tumors

Tissues

Brain tissue

Back to Top